ZEALAND PHARMA A/S |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 598 DKK | -0.08% |
|
+0.08% | +60.24% |
| Apr. 04 | U.S. Futures Up, European Stocks Flat as Powell Reiterates Room for Rate Cuts This Year | DJ |
| Mar. 20 | Zealand Pharma A/S Approves Appointments to the Board | CI |
Evolution of the average Target Price on Zealand Pharma A/S
Price target over the last 5 years
History of analyst recommendation changes
d1d9f5a50843d86a27d1551.dmkkBqyx4tjuGo80NIHws0lCZQ9Wbfk_fAAuRbJvBI0.Hi9Pd8vboJ2sTttuY9G4nnw2L1g3IMwMP3FNLOIqUr1FLXBw5f2y7Zdjtw~4e0d3d92e6a801fa8cc37d30b12e4a50
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
598.5
DKK
Average target price
754.3
DKK
Spread / Average Target
+26.03%
High Price Target
840
DKK
Spread / Highest target
+40.35%
Low Price Target
570
DKK
Spread / Lowest Target
-4.76%
Consensus detail
Consensus revision (last 18 months)
Analysts covering Zealand Pharma A/S
| Goldman Sachs |
Trading Rating
Investor Rating
ESG Refinitiv
B
EPS Revisions
- Stock Market
- Equities
- ZEAL Stock
- Consensus Zealand Pharma A/S
